EmbryoScope+ approved for sales in the USA
Vitrolife AB (publ) has today received market approval for the time-lapse incubator EmbryoScope+ in the USA, the world's third largest market measured in terms of number of IVF treatments.EmbryoScope+ is a time-lapse system with an integrated incubator with a capacity for fifteen patients. Vitrolife is the market leader of time-lapse systems for use in assisted reproduction for undisturbed culture and improved selection of embryos. “We are delighted to now being able to offer also EmbryoScope+ to the clinics in the USA”, says Thomas Axelsson, CEO of Vitrolife. May 12, 2018Gothenburg